Thursday, April 30, 2015
Aeterna Zentaris to Continue Phase III Study of Cancer Drug
Aeterna Zentaris to Continue Phase III Study of Cancer Drug Apr 29, 2015 Pipeline updates are highly awaited events in the pharma/biotech sector as they play an important role in deciding whether or not to invest in a particular company. These updates provide information on experimental drugs and at times [...] Read More
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment